The Senate Finance Committee’s confirmation hearing for two trade specialists appointed by Biden shows an obvious rift with the Executive Branch over recent China trade decisions.
An eye-opening exclusive by the WSJ shows just how much time and energy is being spent by American companies and Silicon Valley venture capitalists investing in semiconductor production…in China. The U.S. needs the CHIPS Act passed this year.
A report by business intel firm Horizon Advisory shows China’s encroachment on the European steel industry. What might it mean for Section 232 tariffs against European steel?
A House committee hearing on the impact of the supply crisis on small businesses left out one key solution: import less, make more here.
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
The Last Word | A Return to American Made By Greg Owens Steel is in short supply in the U.S. and prices are surging, which
Katherine Tai spoke to CSIS this week about China. Some takeaways were better than others.
The Mexican & Guatemalan governments are working against their own peoples’ interests. Rather than weakening our rules of origin, North American leaders should be united in recapturing market share lost to China.
A Deloitte survey of CFOs says that nearly half are facing serious supply chain disruptions. They all want to move away from a China-centric model. But will their new “supply chain resilience” push mean nothing for U.S. manufacturing, everything from Southeas Asia and Mexico?
The recent and ongoing National Defense Authorization Act was an emotional debate over Buy America provisions. Where do our Congressional leaders come down on this issue? Do local manufacturers have any allies in Washington?
